Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.

Goldie JH, Coldman AJ.

Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1727-33.

PMID:
526911
2.

Quantitative model for multiple levels of drug resistance in clinical tumors.

Goldie JH, Coldman AJ.

Cancer Treat Rep. 1983 Oct;67(10):923-31.

PMID:
6627236
3.

Emergence of the drug-resistant phenotype in tumor subpopulations: a hybrid model.

Michelson S, Slate D.

J Natl Cancer Inst. 1989 Sep 20;81(18):1392-401.

PMID:
2778825
4.

A model for metastases formation.

Markovitch S.

Int J Biomed Comput. 1993 Jan;32(1):19-33.

PMID:
8425750
7.

Impact of dose-intense chemotherapy on the development of permanent drug resistance.

Coldman AJ, Goldie JH.

Semin Oncol. 1987 Dec;14(4 Suppl 4):29-33.

PMID:
3686044
8.
9.

A model for tumor response to chemotherapy: an integration of the stem cell and somatic mutation hypotheses.

Goldie JH, Coldman AJ.

Cancer Invest. 1985;3(6):553-64. Review. No abstract available.

PMID:
3910195
10.

Stochastic modeling of drug resistance in cancer.

Komarova N.

J Theor Biol. 2006 Apr 7;239(3):351-66. Epub 2005 Sep 27.

PMID:
16194548
11.

Conflicting objectives in chemotherapy with drug resistance.

Costa MI, Boldrini JL.

Bull Math Biol. 1997 Jul;59(4):707-24.

PMID:
9214850
12.

Quantitative genetic analysis of tumor progression.

Ling V, Chambers AF, Harris JF, Hill RP.

Cancer Metastasis Rev. 1985;4(2):173-92. Review.

PMID:
3893685
13.

Modeling growth kinetics and statistical distribution of oligometastases.

Withers HR, Lee SP.

Semin Radiat Oncol. 2006 Apr;16(2):111-9. Review.

PMID:
16564446
14.

Some drug-resistant models for cancer chemotherapy. Part 1: Cycle-nonspecific drugs.

Usher JR, Henderson D.

IMA J Math Appl Med Biol. 1996 Jun;13(2):99-126.

PMID:
8671582
15.

A mathematical model of drug resistance: heterogeneous tumors.

Panetta JC.

Math Biosci. 1998 Jan 1;147(1):41-61.

PMID:
9401351
16.

A mathematical model of the development of drug resistance to cancer chemotherapy.

Birkhead BG, Rankin EM, Gallivan S, Dones L, Rubens RD.

Eur J Cancer Clin Oncol. 1987 Sep;23(9):1421-7.

PMID:
3678329
17.

Intrinsic versus acquired drug resistance.

Mackillop WJ.

Cancer Treat Rep. 1986 Jun;70(6):817-8. No abstract available.

PMID:
3731144
18.

Role of mathematical modeling in protocol formulation in cancer chemotherapy.

Coldman AJ, Goldie JH.

Cancer Treat Rep. 1985 Oct;69(10):1041-8.

PMID:
2412691
19.

Drug kinetics and drug resistance in optimal chemotherapy.

Costa MI, Boldrini JL, Bassanezi RC.

Math Biosci. 1995 Feb;125(2):191-209.

PMID:
7881194
20.

Changes associated with the development of resistance to imatinib (STI571) in two leukemia cell lines expressing p210 Bcr/Abl protein.

Scappini B, Gatto S, Onida F, Ricci C, Divoky V, Wierda WG, Andreeff M, Dong L, Hayes K, Verstovsek S, Kantarjian HM, Beran M.

Cancer. 2004 Apr 1;100(7):1459-71.

Supplemental Content

Support Center